Exelixis (EXEL) News Today $36.54 +0.80 (+2.24%) Closing price 04:00 PM EasternExtended Trading$36.09 -0.45 (-1.23%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Invesco Ltd. Acquires 3,001,204 Shares of Exelixis, Inc. (NASDAQ:EXEL)Invesco Ltd. increased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 308.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,975,241 shares of the biotechnology company's stock after acquiringApril 15 at 4:58 AM | marketbeat.comWells Fargo & Company MN Has $24.85 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)Wells Fargo & Company MN grew its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1,637.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 746,286 shares of the biotechnology company'April 15 at 4:21 AM | marketbeat.comWellington Management Group LLP Has $4.61 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Wellington Management Group LLP lowered its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 43.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 138,408 shares of the biotechnology company's stock after selling 106,934 shares during the pApril 14 at 3:40 AM | marketbeat.comOak Associates Ltd. OH Sells 9,973 Shares of Exelixis, Inc. (NASDAQ:EXEL)Oak Associates Ltd. OH decreased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 10.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,544 shares of the biotechnology company'sApril 13 at 7:35 AM | marketbeat.comAviva PLC Sells 7,699 Shares of Exelixis, Inc. (NASDAQ:EXEL)Aviva PLC lowered its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 30.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,228 shares of the biotechnology company's stock afApril 13 at 4:57 AM | marketbeat.comLPL Financial LLC Purchases 22,370 Shares of Exelixis, Inc. (NASDAQ:EXEL)LPL Financial LLC lifted its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 26.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,212 shares of the biotechnology company's stock after acqApril 13 at 3:40 AM | marketbeat.comLSV Asset Management Purchases 67,470 Shares of Exelixis, Inc. (NASDAQ:EXEL)LSV Asset Management raised its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,169,847 shares of the biotechnology company's stockApril 12 at 8:09 AM | marketbeat.comFederated Hermes Inc. Increases Position in Exelixis, Inc. (NASDAQ:EXEL)Federated Hermes Inc. lifted its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 82.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 408,932 shares of the biotechnology company's stock after buying an addiApril 12 at 5:39 AM | marketbeat.comResona Asset Management Co. Ltd. Purchases New Stake in Exelixis, Inc. (NASDAQ:EXEL)Resona Asset Management Co. Ltd. purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 46,798 shares of the biotechnologApril 12 at 5:08 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Stock Holdings Reduced by Alliancebernstein L.P.Alliancebernstein L.P. lowered its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 390,775 shares of the biotechnology company'April 12 at 4:25 AM | marketbeat.comApplied Finance Capital Management LLC Buys Shares of 7,361 Exelixis, Inc. (NASDAQ:EXEL)Applied Finance Capital Management LLC purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 7,361 shares of the biotechnology company's stock, valuApril 11, 2025 | marketbeat.comGreenland Capital Management LP Invests $333,000 in Exelixis, Inc. (NASDAQ:EXEL)Greenland Capital Management LP purchased a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,000 shares of the biotechnApril 11, 2025 | marketbeat.comRussell Investments Group Ltd. Cuts Position in Exelixis, Inc. (NASDAQ:EXEL)Russell Investments Group Ltd. lowered its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 25.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 725,968 shares of the biotechnology company's stock after sellApril 11, 2025 | marketbeat.comLandscape Capital Management L.L.C. Reduces Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Landscape Capital Management L.L.C. trimmed its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 78.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,067 shares of the biotechnology company's stock after seApril 11, 2025 | marketbeat.comBiocom California Appoints Two New Members to its Board of DirectorsApril 10, 2025 | finance.yahoo.comPrivate Sector Steps Up in Cancer Research as Federal Support WaversApril 10, 2025 | baystreet.caRenaissance Technologies LLC Sells 64,051 Shares of Exelixis, Inc. (NASDAQ:EXEL)Renaissance Technologies LLC decreased its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,295,865 shares of the biotechnology company's stock aApril 10, 2025 | marketbeat.comPrudential PLC Purchases Shares of 33,574 Exelixis, Inc. (NASDAQ:EXEL)Prudential PLC acquired a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 33,574 shares of the biotechnology company's stock, valued at approxApril 10, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Grantham Mayo Van Otterloo & Co. LLCGrantham Mayo Van Otterloo & Co. LLC raised its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 80.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 151,153 shares of the biotechnology coApril 9, 2025 | marketbeat.comExodusPoint Capital Management LP Makes New $2.36 Million Investment in Exelixis, Inc. (NASDAQ:EXEL)ExodusPoint Capital Management LP acquired a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 70,801 shares of the biotechnology company's stock, valApril 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 63,037 Shares of Exelixis, Inc. (NASDAQ:EXEL)Massachusetts Financial Services Co. MA lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 19.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 263,217 shares of the biotechnoApril 9, 2025 | marketbeat.comRiverwater Partners LLC Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)Riverwater Partners LLC purchased a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 57,444 shares of the biotechnology company's stock,April 7, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Stake Raised by Franklin Resources Inc.Franklin Resources Inc. raised its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 12.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 891,985 shares of the biotechnology compaApril 7, 2025 | marketbeat.comExelixis (EXEL) Gets a Buy from RBC CapitalApril 5, 2025 | markets.businessinsider.comCalifornia Public Employees Retirement System Has $44.32 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL)California Public Employees Retirement System reduced its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,331,027 sharApril 4, 2025 | marketbeat.comSchroder Investment Management Group Acquires 260,940 Shares of Exelixis, Inc. (NASDAQ:EXEL)Schroder Investment Management Group increased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 87.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 558,798 shares of the biotechApril 4, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,314,575 shares of the biotechnology company's stock after selling 1,116,07April 4, 2025 | marketbeat.comThe Smartest Biotech Stocks to Buy With $50April 3, 2025 | fool.comNorges Bank Acquires Shares of 2,848,870 Exelixis, Inc. (NASDAQ:EXEL)Norges Bank bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,848,870 shares of the biotechnology company's stock, valued at approximately $94,867,000. Norges BaApril 3, 2025 | marketbeat.comPrudential Financial Inc. Purchases 94,283 Shares of Exelixis, Inc. (NASDAQ:EXEL)Prudential Financial Inc. increased its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 479.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 113,965 shares of the biotechnology company'sApril 3, 2025 | marketbeat.comAmerican Century Companies Inc. Has $13.85 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL)American Century Companies Inc. cut its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 415,865 shares of the biotechnology company's stock after selling 47,750 shares duringApril 3, 2025 | marketbeat.comIs Exelixis, Inc. (EXEL) The Most Profitable Biotech Stock To Buy Right Now?April 2, 2025 | insidermonkey.comTrexquant Investment LP Has $19.82 Million Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Trexquant Investment LP grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 39.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 595,146 shares of the biotechnology company's stock after purchasingApril 2, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Pictet Asset Management Holding SAPictet Asset Management Holding SA cut its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 6.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 821,309 shares of the biotechnology company'sApril 2, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Acquires 1,613,482 Shares of Exelixis, Inc. (NASDAQ:EXEL)Arrowstreet Capital Limited Partnership raised its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 104.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,159,395 shares of the biotechnology company's stockApril 1, 2025 | marketbeat.comElo Mutual Pension Insurance Co Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)Elo Mutual Pension Insurance Co purchased a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 18,198 shares of the biotechnology coApril 1, 2025 | marketbeat.comExelixis Launches Special Equity Award ProgramMarch 31, 2025 | tipranks.comNew Age Alpha Advisors LLC Purchases New Shares in Exelixis, Inc. (NASDAQ:EXEL)New Age Alpha Advisors LLC acquired a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 63,149 shares of the biotechnology company's stockMarch 31, 2025 | marketbeat.comNEOS Investment Management LLC Has $1.64 Million Holdings in Exelixis, Inc. (NASDAQ:EXEL)NEOS Investment Management LLC increased its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 21.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 49,256 shares of the biotechnology company's stock after purchasing an additional 8,674 shares durMarch 31, 2025 | marketbeat.comFY2026 EPS Estimates for Exelixis Increased by AnalystExelixis, Inc. (NASDAQ:EXEL - Free Report) - Stock analysts at Leerink Partnrs increased their FY2026 earnings per share estimates for shares of Exelixis in a report issued on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now anticipates that the biotechnology company will post earningMarch 31, 2025 | marketbeat.comGuggenheim Remains a Buy on Exelixis (EXEL)March 30, 2025 | markets.businessinsider.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Blair William & Co. ILBlair William & Co. IL lowered its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 39.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 457,570 shares of the biotechnology company's stock after selling 300,March 30, 2025 | marketbeat.com7,019 Shares in Exelixis, Inc. (NASDAQ:EXEL) Acquired by Meiji Yasuda Asset Management Co Ltd.Meiji Yasuda Asset Management Co Ltd. acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 7,019 shares of the biotechnology company's stock, valuedMarch 30, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. lifted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,429,252 shares of the biotechnology comMarch 30, 2025 | marketbeat.comLeerink Partnrs Has Positive Outlook of Exelixis Q1 EarningsExelixis, Inc. (NASDAQ:EXEL - Free Report) - Analysts at Leerink Partnrs lifted their Q1 2025 earnings per share estimates for Exelixis in a report released on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now anticipates that the biotechnology company will post earnings per share of $March 29, 2025 | marketbeat.comdenkapparat Operations GmbH Takes $713,000 Position in Exelixis, Inc. (NASDAQ:EXEL)denkapparat Operations GmbH purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 21,410 shares of the biotechnology company's stock, valued at appMarch 29, 2025 | marketbeat.comWINTON GROUP Ltd Has $1.32 Million Position in Exelixis, Inc. (NASDAQ:EXEL)WINTON GROUP Ltd cut its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 85.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 39,536 shares of the biotechnology company's stock after selling 229,317 sharesMarch 29, 2025 | marketbeat.comEntryPoint Capital LLC Has $281,000 Stake in Exelixis, Inc. (NASDAQ:EXEL)EntryPoint Capital LLC reduced its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 54.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,433 shares of the biotechnology company's stock after selling 10,230 shares during theMarch 29, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Receives "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $40.00 price target on shares of Exelixis in a research note on Thursday.March 28, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Corebridge Financial Inc.Corebridge Financial Inc. cut its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 325,795 shares of the biotechnology company's stock after selling 14,342 shares during the period. Corebridge FinMarch 28, 2025 | marketbeat.com Remove Ads Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼1.360.80▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2212▲EXEL Articles Average Week Remove Ads Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Neurocrine Biosciences News Exact Sciences News Halozyme Therapeutics News Repligen News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXEL Stock Free EXEL Stock Alerts